ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

VSTM Verastem Inc

10,36
0,38 (3,81%)
02 Mai 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Verastem Inc VSTM NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,38 3,81% 10,36 19:12:15
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
10,01 9,81 10,45 10,36 9,98
mais cotações »

Notícias Recentes

Data Hora Fonte Título
18/04/202417:05BWVerastem Oncology Announces Appointment of John Hayslip,..
04/04/202408:30BWVerastem Oncology Announces Inducement Grants Under Nasdaq..
18/03/202408:00BWGlobal Patient Survey Results Reveal Significant Negative..
14/03/202417:05BWVerastem Oncology Reports Fourth Quarter and Full Year 2023..
11/03/202408:30BWVerastem Oncology Announces Multiple Oral Presentations at..
05/03/202419:27BWVerastem Oncology Receives Orphan Drug Designation from FDA..
05/03/202418:30BWVerastem Oncology Announces Preclinical Presentations for..
29/01/202409:00BWVerastem Oncology Outlines Key 2024 Strategic Priorities and..
18/01/202418:00BWVerastem Oncology Granted Fast Track Designation for..
11/01/202409:00BWVerastem Oncology to Participate in the B. Riley Securities..
05/01/202409:00BWVerastem Oncology Announces Inducement Grants Under Nasdaq..
18/12/202309:00BWVerastem Oncology Selects Oral KRAS G12D Inhibitor..
13/12/202309:00BWVerastem Oncology Announces Initiation of a Confirmatory..
13/11/202309:00BWNew Healthcare Professional Component of Let’s Talk About..
08/11/202318:12BWVerastem Oncology Reports Third Quarter 2023 Financial..
07/11/202309:00BWFirst-Of-Its-Kind, Multi-National Patient Impact Survey..
06/11/202309:00BWVerastem Oncology Announces Efficacy and Safety Data of..
26/10/202317:05BWVerastem Oncology Strengthens Executive Leadership Team with..
18/10/202317:50BWVerastem Oncology Announces Inducement Grants Under Nasdaq..
14/10/202313:30BWVerastem Oncology Announces Initial Results of RAMP 203..
06/10/202308:00BWVerastem Oncology Announces Inducement Grants Under Nasdaq..
28/09/202315:15BWVerastem Presents Avutometinib and Defactinib Combination..
05/09/202308:00BWVerastem Oncology to Participate in Upcoming Investor..
28/08/202308:00BWVerastem Oncology Enters Discovery and Development..
08/08/202317:05BWVerastem Oncology Reports Second Quarter 2023 Financial..
11/07/202308:00BWVerastem Oncology Announces Promotion of Dan Paterson to..
10/07/202317:05BWVerastem Oncology Announces Inducement Grants Under Nasdaq..
05/07/202317:05BWVerastem Oncology Announces Design for Confirmatory Trial of..
16/06/202306:00BWVerastem Oncology Announces Pricing of $85.0 Million Public..
15/06/202317:00BWVerastem Oncology Announces Proposed Public Offering of..
31/05/202310:11BWVerastem Oncology Announces Reverse Stock Split
25/05/202318:05BWUpdated Data from Part A of Verastem Oncology's RAMP 201..
16/05/202308:00BWVerastem Oncology Appoints Karin Tollefson, PhD, to Board of..
09/05/202317:05BWVerastem Oncology Reports First Quarter 2023 Financial..

Seu Histórico Recente

Delayed Upgrade Clock